An immunohistochemical and molecular analysis of papillary proliferation of the endometrium

C.J.R. Stewart, S. Bigby, T. Giardina, F. Grieu-Iacopetta, B Amanuel

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Papillary proliferations of the endometrium (PPEs) are uncommon lesions that are often associated with endometrial polyps. PPEs occasionally precede or co-exist with atypical endometrial hyperplasia or adenocarcinoma, but their pathogenesis and relationship to endometrial neoplasia is uncertain. In the present study 11 PPEs, including eight benign papillary proliferations (BPPs) and three complex papillary hyperplasias (CPHs) were examined immunohistochemically for expression of PAX2, BAF250a, p16, β-catenin and DNA mismatch repair (MMR) proteins. Molecular analysis was also performed on the CPHs using targeted next generation sequencing (NGS). All PPEs demonstrated at least one immunohistochemical abnormality with altered expression of p16 and PAX2 in nine and seven cases, respectively, and β-catenin in one case. However, none of the cases showed loss of BAF250a or MMR protein staining. All CPHs showed KRAS mutations with additional mutations in AKT1 and FBXW7 in one case each, and both PIK3CA and CTNNB1 in the remaining case. Therefore, PPEs demonstrate immunophenotypical and molecular overlap with endometrial endometrioid neoplasia, although loss of BAF250a and MMR protein function do not appear to contribute significantly to these lesions. KRAS mutations may be important drivers in CPHs but this finding needs to be confirmed in larger studies.

Original languageEnglish
Pages (from-to)286-292
Number of pages7
Issue number3
Publication statusPublished - 1 Apr 2018


Dive into the research topics of 'An immunohistochemical and molecular analysis of papillary proliferation of the endometrium'. Together they form a unique fingerprint.

Cite this